SEC

SEC Charges CBA Pharma and Two Executives with Fraud

The SEC has charged CBA Pharma, Inc. and two executives with defrauding investors in a securities offering that raised approximately $4.1 million. The company allegedly misrepresented the effectiveness and FDA approval status of its cancer drug, CBT-1.

SEC v. Barrington Asset Management - Enforcement Action Dismissal and Settlement

The SEC has dismissed its civil enforcement action against Barrington Asset Management, Inc. and Gregory D. Paris. Simultaneously, the SEC instituted a settled administrative proceeding against the same parties. The dismissal and settlement occurred on February 10, 2026.

SEC Technical Amendments to Commission Forms

The SEC has issued a final rule making technical amendments to its commission forms. These amendments are administrative in nature and do not alter existing disclosure requirements or regulatory obligations for public companies, broker-dealers, or fund managers.

SEC Technical Amendments to Commission Rules and Forms

The SEC has issued a final rule making technical amendments to its existing rules and forms. This action is part of routine administrative updates to ensure clarity and accuracy in regulatory filings and procedures.

SEC Delegation of Authority to Director of Investment Management

The SEC has issued a final rule amending its delegation of authority to the Director of the Division of Investment Management. This rule clarifies and updates the specific functions and responsibilities that can be delegated to the Director. The changes are effective upon publication in the Federal Register.

SEC Technical Amendment to Delegation of Authority Rules

The SEC has adopted a technical amendment to its delegation of authority rules. This amendment corrects an outdated cross-reference in the rules that delegate authority to the Commission's staff to grant certain exemptions from Rule 612 of Regulation NMS.

SEC Proposes Amending Small Business Definitions for Investment Companies and Advisers

The SEC has proposed amendments to the definitions of 'small business' and 'small organization' for investment companies and advisers under the Regulatory Flexibility Act. The proposal aims to increase asset-based thresholds and establish a mechanism for future inflation adjustments. Public comments are due by March 13, 2026.